Maximum Daily Dose of Propranolol in Adults
For adults, the maximum daily dose of propranolol varies by indication: 160 mg/day for hypertension and supraventricular tachycardia, 240 mg/day for angina and migraine prophylaxis, and up to 640 mg/day for hypertrophic subaortic stenosis, with the FDA-approved extended-release formulation allowing up to 640 mg/day in select cases.
Indication-Specific Maximum Doses
Hypertension
The 2017 ACC/AHA hypertension guidelines establish 80-160 mg/day as the usual dose range for propranolol IR (immediate release) given twice daily, or propranolol LA (long-acting) given once daily 1. The FDA label for extended-release formulations specifies that while the usual maintenance dose is 120-160 mg once daily, some patients may require up to 640 mg/day to achieve adequate blood pressure control 2.
Cardiac Arrhythmias
For supraventricular tachycardia and atrial fibrillation rate control, the 2016 ACC/AHA/HRS guidelines recommend 40-160 mg daily in divided or single doses with long-acting formulations as the maximum maintenance dose 3, 4. The 2024 atrial fibrillation guidelines similarly cite propranolol dosing of 10-40 mg three to four times daily for the immediate-release formulation 5.
For acute arrhythmia management, intravenous propranolol is dosed at 0.5-1 mg over 1 minute, repeated up to a total dose of 0.1 mg/kg (approximately 7 mg for a 70 kg patient) 6.
Angina Pectoris
The FDA label indicates that for angina, the average optimal dosage is 160 mg once daily for extended-release formulations, with safety and efficacy of doses exceeding 320 mg/day not established 2.
Migraine Prophylaxis
For migraine prevention, the usual effective dose range is 160-240 mg once daily, with the FDA label stating this as the maximum recommended dose 2.
Hypertrophic Subaortic Stenosis
This indication allows for higher dosing, with 80-160 mg once daily as the usual range, though the FDA label permits titration beyond this in select cases 2.
Important Clinical Considerations
Dose-Response Relationship
Research evidence reveals a critical nuance: most of propranolol's antihypertensive effect occurs at relatively low doses (80-160 mg/day), with minimal additional blood pressure reduction at higher doses 7, 8. One study demonstrated that doses of 80,160, and 240 mg twice daily produced no greater hypotensive response than 40 mg twice daily, though higher doses improved the ability to achieve target blood pressure in more patients 8.
Antiarrhythmic Effects at Higher Doses
For ventricular arrhythmia suppression, some patients require substantially higher doses. A landmark study found that while only one-third of patients responded to doses ≤160 mg/day, an additional 40% responded with doses of 200-640 mg/day 9. Importantly, the plasma concentrations required for antiarrhythmic effects often exceeded those needed for beta-blockade, suggesting mechanisms beyond simple beta-receptor antagonism.
Pediatric Dosing (Infantile Hemangiomas)
For context, pediatric guidelines for infantile hemangiomas recommend 2-3 mg/kg/day as the maintenance dose, with a maximum of 3 mg/kg/day for non-responders 10, 11. This translates to substantially lower absolute doses than adult indications but demonstrates the drug's safety profile when appropriately monitored.
Critical Safety Parameters
Avoid abrupt cessation of propranolol, particularly in patients with ischemic heart disease, as this can precipitate rebound hypertension, angina, or myocardial infarction 1. When discontinuing, reduce dosage gradually over several weeks.
Absolute contraindications include:
- Second or third-degree heart block (without pacemaker)
- Decompensated heart failure
- Cardiogenic shock
- Severe reactive airway disease
- Sinus bradycardia
Monitor carefully for:
- Bradycardia (heart rate <50 bpm typically warrants dose reduction)
- Hypotension (systolic BP <100 mmHg)
- Bronchospasm in patients with underlying lung disease
- Masking of hypoglycemia symptoms in diabetics
Practical Dosing Algorithm
- Start low: Begin with 40-80 mg/day (divided doses for IR, once daily for LA)
- Titrate based on indication:
- Hypertension: Increase to 120-160 mg/day; rarely exceed 320 mg/day
- Angina/Migraine: Target 160-240 mg/day maximum
- Arrhythmias: May require 200-640 mg/day for suppression
- Assess response at each dose for 3-7 days before further titration
- Monitor heart rate and blood pressure at each visit
- Consider formulation: Extended-release allows once-daily dosing and may improve adherence
The evidence consistently shows that exceeding 160 mg/day for hypertension provides minimal additional benefit while increasing side effect risk 7, 8. However, for specific indications like refractory arrhythmias or hypertrophic cardiomyopathy, doses up to 640 mg/day may be necessary and are FDA-approved 2, 9.